Mast Cell Activation Profiles in Perioperative Immediate Hypersensitivity Reactions: A GERAP Network Study
Journal of Investigational Allergology and Clinical Immunology · 22.07.2026 · 37 (4)
DOI: 10.18176/jiaci.1179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, online erschienen am 22.07.2026. Verfasst von Charles Tacquard und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, Strasbourg University Hospital, Strasbourg France.
Abstract (Originalsprache)
Background
Perioperative immediate hypersensitivity reactions (POHRs) are potentially fatal complications of anesthesia. Although tryptase is a cornerstone biomarker for mast cell activation (MCA), its diagnostic limitations call for a better understanding of the underlying mechanisms and phenotypes of POHRs to guide management.
Objective
Compare the phenotypes of patients who experience POHRs based on their MCA profiles using tryptase and histamine assays.
Methods
This retrospective multicenter study included patients assessed by the GERAP Network who experienced POHRs from 2017 to 2024. Clinical characteristics and biomarker correlation were analyzed across MCA profiles. MCA profiles were determined based on the presence of MCA (peak tryptase >1.2×baseline tryptase+2 μg/L; NoMCA vs MCA) and a peak tryptase value (elevated if ≥8 μg/L; low tryptase [LT] vs high tryptase [HT]) or histamine release (elevated if ≥10 nmol/L).
Results
MCA was recorded in 626 of the 930 patients (67%). HT-MCA and LT-NoMCA were the most frequent profiles, detected in 60% and 27% of patients, respectively. POHRs were more severe in the HT-MCA group than in the LT-NoMCA group (85% vs 43%; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia and Intensive Care, Strasbourg University Hospital, Strasbourg France.
- UMR_S1255, Strasbourg, France.
- Department of Immunology and Histocompatibility, Caen University Hospital, Caen, France.
- Normandie Univ, UNICAEN, UMR-S 1237, Caen, France.
- University Paris Cité, Paris, France, Anesthesiology and Critical Care Medicine Department, DMU PARABOL, Bichat Hospital, AP-HP, Paris, France.
- Antibody in Therapy and Pathology, Pasteur Institute, UMR 1222 INSERM, Paris, France.
Zitieren
APA
Tacquard, C., Serrier, J., Gouel-Chéron, A., Caron, J., Colas, L., De Chaisemartin, L., Franchina, S., Le Mauff, B., Neukirch, C., Pelletier de Chambure, D., Smilov, M., Viville, S., Demoly, P., Mertes, P. M., & GERAP study group (2026). Mast Cell Activation Profiles in Perioperative Immediate Hypersensitivity Reactions: A GERAP Network Study. Journal of Investigational Allergology and Clinical Immunology, 37(4). https://doi.org/10.18176/jiaci.1179
Vancouver
Tacquard C, Serrier J, Gouel-Chéron A, Caron J, Colas L, De Chaisemartin L, et al. Mast Cell Activation Profiles in Perioperative Immediate Hypersensitivity Reactions: A GERAP Network Study. Journal of Investigational Allergology and Clinical Immunology. 2026;37(4). doi:10.18176/jiaci.1179
BibTeX
@article{Tacquard2026,
author = {Tacquard, Charles and Serrier, Julien and Gouel-Chéron, Aurélie and Caron, Juliette and Colas, Luc and De Chaisemartin, Luc and Franchina, Sébastien and Le Mauff, Brigitte and Neukirch, Catherine and Pelletier de Chambure, Diane and Smilov, Magdalena and Viville, Simon and Demoly, Pascal and Mertes, Paul Michel and GERAP study group, GERAP study group},
title = {Mast Cell Activation Profiles in Perioperative Immediate Hypersensitivity Reactions: A GERAP Network Study},
journal = {Journal of Investigational Allergology and Clinical Immunology},
year = {2026},
volume = {37},
number = {4},
doi = {10.18176/jiaci.1179}
}
EUVIMED